USPTO serial 88864117
ARMS-I
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HAYS, CANDACE W
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ARMS-I?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian E. Turung
Brian E. Turung ULMER & BERNE LLP1660 West 2nd StreetSkylight Office Tower, Suite 1100CLEVELAND, OH 44113Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicine for use in the treatment and prevention of infectious diseases, asthma, allergy, and inflammatory conditions or diseases; eye drops, medicated eyewash, eye lubricant, saline solution for disinfecting contact lenses; cough and cold treatment preparations for adults and children; allergy medication; nasal decongestants and sprays; antihistamines; antidiarrheal preparations; digestive supplements; liquid elixirs for the treatment of cold and allergies; laxatives; antacids; aspirin and non-aspirin cold, flu and sinus preparations; pediatric and adult pain relievers; expectorants; syrups for treating sore throat; throat lozenges; cough suppressants being cough drops; liquid preparations for treating coughs and colds; anesthetic creams; anti-itch preparations, namely, anti-inch creams, anti-itch ointments; antibiotic preparations; athlete's foot preparations; antibiotic ointments, namely, bacitracin ointment; calamine lotion; medicated cool/hot ointments for muscle and pain relief; topical analgesic creams, namely, muscle rubs; medicated diaper rash ointments; hydrocortisone preparations, namely, hydrocortisone cream; povidone solution for use as an anti-infective; vitamin A and D ointment for medical use in treating dermatological conditions; vaporing ointment for treatment of chest congestion; zinc oxide ointment for treatment of pain relief and sunburns; acne medications and medicated pads and cream for treating acne; antiseptic mouth rinse; medicated skin cream; non-medicated therapeutic skin preparations for treatment of acne; medicated foot and body powders; anti-gas and antacid preparations; heartburn relief tablets; glycerin suppositories being pharmaceutical preparations for treating constipation; clortrimazole cream for use in treating athlete's foot; capsaicin liquid for use in treating muscle and joint pain; Topical analgesic creams, namely, arthritis cream; medicated body soap; medicated rubbing compound; anti-allergy tablets for symptomatic relief of upper respiratory allergies; topical anesthetic creams and ointments; analgesics tablets and elixirs; all-purpose disinfecting preparations for use on the body surface of a human; antifungal preparations for use on the body surface of a human; antiseptic liquid bandages; antiseptic preparations for consumption and for use on the body surface of a human; hand-sanitizing preparations for use on the body surface of a human; chemical preparations for sanitary use for use on the body surface of a human; medicated chewing gum; mouth and oral lozenges, namely, cough lozenges, medicated lozenges, throat lozenges, zinc supplement lozenges; medicated mouth washes; medicated mouth and oral sanitizer, namely, mouth cavity cleansers; medicated candy; medicated mouth care products, namely, mouth and oral antiseptics; medicated mouth care products, namely, medicated brush-on oral care gels; dietary supplement in the form an orally ingested gel for boosting energy; medicated mouth care and treatment preparations and moisturizing mouth washes for relief of dry mouth and associated symptoms and conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 5, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 4, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 30, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 5, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 5, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 15, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 31, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 2, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 8, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 8, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 8, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 8, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 1, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 1, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 1, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 10, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 15, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |